In the context of overcoming resistance to venetoclax, or improving its effects in AML, preclinical studies have shown promising results in studies analyzing molecules targeting mitochondrial respiration or structure, which include those disrupting the mitochondrial electron transport chain, mitochondrial translation, mitochondrial DNA replication, or mitochondrial protease ClpP [42]. Here, CLPP is linked to acute myeloid leukemia.